MedPath

Effects of Semi-standarized Acupuncture in Chronical Symptomatic Osteoarthritis of the Knee Through: A Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Osteoarthritis, Knee
Registration Number
NCT05096806
Lead Sponsor
Universitat de Girona
Brief Summary

Introduction:

Knee osteoarthritis is a long-term rheumatic disease with a significant impact on the patient's quality of life and the socio-economic development of societies. The usual treatment consists of non-steroidal anti-inflammatory drugs as a palliative measure. The decrease in the beneficial effect and the appearance of serious long-term adverse effects make it necessary to look for other therapeutic procedures. Acupuncture is a non-pharmacological treatment that could reduce pain and improve functionality in this condition, however current scientific evidence is limited. A previous study has observed a clinical improvement in the combination of sensitized local and peripheral points in the treatment of knee osteoarthritis but studies with a larger sample are needed to confirm these results.

Objective:

Assess the effectiveness of acupuncture using a combination of local and peripheral sensitized points in the treatment of active knee osteoarthritis.

Methods:

A randomized clinical trial will be performed in a hospital centre with 2 groups. The control group will standard treatment plus transcutaneous electrical nerve stimulation, while the intervention group will receive acupuncture in addition to standard care. Study outcomes will be pain, quality of life, function, exercise adherence, drug intake, adverse effects, and body mass index. There will be a 12-month post-intervention follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
56
Inclusion Criteria
  • Usual painful episode of 3 months or more
  • Morning stiffness of 15 minutes or more
  • Pain equal to or greater than 5 on the VAS
  • Grade 2 or greater on the Kellgren-Lawrence scale
Exclusion Criteria
  • Corticosteroid infiltration in the 3 months prior to recruitment
  • Rehabilitation treatment one month prior to recruitment
  • With a knee prosthesis
  • Needle phobia
  • Pregnancy
  • With pacemakers
  • Cardiac arrhythmias

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from Baseline Pain at post interventionAt the end of the intervention, at the 4th week of the study

Pain will be assessed using the visual analogue scale (VAS)

Change from Baseline Quality of life at postinterventionAt the end of the intervention, at the 4th week of the study

Quality of life will be assessed using the SF-12 questionnaire. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.

Change from Baseline Knee function at postinterventionAt the end of the intervention, at the 4th week of the study

Knee function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

Secondary Outcome Measures
NameTimeMethod
Change from Baseline Knee function at 4 months16 weeks afther the end of the intervention, at the 20th week of the study

Knee function will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

Change from Baseline Quality of life at 4 months16 weeks afther the end of the intervention, at the 20th week of the study

Quality of life will be assessed using the SF-12 questionnaire. Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.

Change from Baseline Pain at 4 months16 weeks afther the end of the intervention, at the 20th week of the study

Pain will be assessed using the visual analogue scale (VAS)

Adverse events postinterventionthrough study completion, an average of 1 year

Any adverse event related with the treatments will be will be noted in a collection sheet.

Drug intake postinterventionthrough study completion, an average of 1 year

Rescue drug intake will be collected in the data collection notebooks

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.